MAPT and Alzheimer disease: Because of the structural differences between the Tau amyloid conformers observed in different tauopathies (33), it would be of interest to investigate the chaperone disaggregation capacity on Sarkosyl-insoluble material from other tauopathies besides AD, especially to compare 3R- and 4R-only diseases.